FDA Inspection 807330 — Andreas H. Diacon, M.D., Ph.D
The FDA completed an inspection of Andreas H. Diacon, M.D., Ph.D on October 19, 2012 in Cape Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cape Town (South Africa)
Additional Details
Clinical Investigator (CI)